KalshiKullanılabilirliği kontrol etKYC gerekli%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel ima edilen olasılık
Before Jan 1, 2032 59%6 seçenek arasında lider
Piyasa kalitesi
47 / 100
Düşük kalite24s Hacim
₺4,6 B
Likidite
₺324,1 B
Orta likiditeSpread
5.0 pt
Orta spreadPiyasa verileri
13 dakika önce güncellendi
14 May 26 02:00 UTC1 Oca 28 04:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
Will the FDA approve cytisinicline for smoking cessation?
KalshiWill the FDA approve CagriSema?
KalshiWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any strain of influenza before 2028?
Manifold MarketsKurallar
If the FDA approves midomafetamine / MDMA for PTSD for marketing the named outcome, then the market resolves to Yes.
Uzlaşma kaynağı:Food and Drug Administration
- An approval is defined as:
- For new drugs: FDA issuance of an approval letter for a New Drug Application (NDA) or Biologics License Application (BLA) For already-marketed drugs seeking new indications: FDA approval of a supplemental NDA (sNDA) or supplemental BLA (sBLA) for the specific indication referenced For generic drugs: FDA approval of an Abbreviated New Drug Application (ANDA) For biosimilars: FDA approval of a 351(k) application
- The following constitute approvals that trigger the Payout Criterion:
- Standard approval (traditional approval based on clinical benefit) Accelerated approval (based on surrogate endpoints) Approval with Risk Evaluation and Mitigation Strategy (REMS) Approval with restricted distribution or indication limitations, except compassionate use/expanded access programs
- The following do NOT constitute approvals:
Açık piyasalar
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Toplam Hacim
- ₺883,7 Mn
- 24s Hacim
- ₺3 Mn
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No98%
- Yes2%
- Toplam Hacim
- ₺92,6 Mn
- 24s Hacim
- ₺768,9 B
KALSHIPandemic in 2026?
- No96%
- Yes-1.0pt4%
- Toplam Hacim
- ₺35,3 Mn
- 24s Hacim
- ₺747,5 B
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000-1.0pt97%
- Above 600061%
+2 daha fazla sonuç
- Toplam Hacim
- ₺49,1 Mn
- 24s Hacim
- ₺145,8 B
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Toplam Hacim
- ₺52,1 Mn
- 24s Hacim
- ₺99,2 B
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 daha fazla sonuç
- Toplam Hacim
- ₺1,8 Mn
- 24s Hacim
- ₺73,4 B
- Healthcare AI adoption in September
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Sık sorulan sorular
- Will the FDA approve MDMA for PTSD? için güncel oranlar nedir?
- Kalshi, 11 Eylül 2026 itibarıyla Before Jan 1, 2032 için 59% fiyatlıyor.
- Will the FDA approve MDMA for PTSD? ne zaman sonuçlanacak?
- Will the FDA approve MDMA for PTSD? için öngörülen sonuçlanma tarihi 1 Ocak 2028.
- Will the FDA approve MDMA for PTSD? nasıl sonuçlandırılıyor?
- Kalshi bu piyasayı şu şekilde sonuçlandırır: If the FDA approves midomafetamine / MDMA for PTSD for marketing the named outcome, then the market resolves to Yes.